IRIS

Sfoglia per Autore  

Opzioni
Mostrati risultati da 1 a 20 di 204
Titolo Data di pubblicazione Autore(i) File
Obesity in Italy: An Empirical Analysis of Healthcare Consumption, Quality of Life and Comorbidities 1-gen-2025 Brenna, Elenka; Jommi, Claudio
Mesenchymal Cell-Free and Cell-Based Therapy in Regenerative Medicine A Crucial Exploration of Formulation, GMP Production, Regulatory Approval, and Market Access 1-gen-2025 Bari, E.; Torre, M. L.; Jommi, C.
Single-Inhaler Triple Therapy in Primary Care Across Europe: Expert Panel Consensus on the Consequences of Payer-Driven Access Rules and Call to Action 1-gen-2025 Di Marco, Fabiano; Shahaj, Orjola; Valipour, Arschang; Legrand, Bertrand; Jommi, Claudio; Micheletto, Claudio; Vogelmeier, Claus; Freeman, Daryl; Kocks, Janwillem; Alves, Luis; Rubio, Myriam; Peché, Rudi; Palkonen Snr, Susanna; Winders, Tonya; Roche, Nicolas
The Costs of Digital Health Interventions to Improve Immunization Data in Low- and Middle-Income Countries: Multicountry Mixed Methods Study 1-gen-2025 Federici, Carlo; Verykiou, Maria; Cavazza, Marianna; Olomi, Willyhelmina; Irakiza, Piero; Kayumba, Kizito; Rodriguez, Edith; Castillo Mendoza, Luis Enrique; Malvolti, Stefano; Hugo, Claire; Ntinginya, Nyanda Elias; Camara, Souleymane; Sabi, Issa; Sano, Nagnouma; Sibomana, Hassan; Condo, Jeanine; Torbica, Aleksandra; Jommi, Claudio; Mantel, Carsten; Mangiaterra, Viviana
Horizon scanning and drug expenditure for rare diseases: three-year predictive model in Italy 2025–2027 1-gen-2025 Marcellusi, Andrea; Cazzato, Daniela; Guarnotta, Giulio; Aiello, Andrea; Bonfanti, Marzia; Bitonti, Rossella; Guardigni, Melissa; Lucchetti, Chiara; Luccini, Fulvio; Canonico, Pier Luigi; Jommi, Claudio
Impact of comprehensive genomic profiling and molecular tumour board on costs and access to tailored therapies: real-world observational study 1-gen-2025 De Micheli, Valentina; Agnelli, Luca; Conca, Elena; Rabsiun Aramburu, Victoria Lucia; Baggi, Anna; Vingiani, Andrea; Duca, Matteo; Perrone, Federica; Tamborini, Elena; Piccolo, Alberta; Lorenzini, Daniele; Busico, Adele; Capone, Iolanda; Niger, Monica; Proto, Claudia; Vernieri, Claudio; Manoukian, Siranoush; Gancitano, Giovanni; Ferrario, Matteo; Franzini, Jean Marie; De Braud, Filippo; Pruneri, Giancarlo; Jommi, Claudio
Pivotal Studies for Drugs About to Be Launched for Rare Diseases: Will They Better Support Health Technology Assessment and Market Access than in the Past? 1-gen-2025 Jommi, Claudio; Bonfanti, Marzia; Guardigni, Melissa; Aiello, Andrea; Marcellusi, Andrea; Canonico, Pier Luigi; Luccini, Fulvio; Lucchetti, Chiara
Paving the road for a successful EU HTA Reform implementation 1-gen-2025 Severens, Hans; Dillon, Andrew; Meyer, Francois; Jommi, Claudio; Lipska, Iga; Canonico, Pier-Luigi; Solà-Morales, Oriol; Altmann, Herbert
Value Attribution for Combination Treatments: Two Potential Solutions for an Insoluble Problem 1-gen-2025 Ciani, Oriana; Jommi, Claudio
Spending caps for pharmaceuticals within the pharmaceutical policies framework: critical issues and reform options 1-gen-2025 Jommi, Claudio
Longitudinal validation of the PROFFIT questionnaire to assess financial toxicity in cancer patients 1-gen-2025 Arenare, L.; Porta, C.; Barberio, D.; Terzolo, S.; Zagonel, V.; Pisconti, S.; Del Mastro, L.; Pinto, C.; Bilancia, D.; Cinieri, S.; Rizzo, M.; Migliaccio, G.; Montesarchio, V.; Del Campo, L.; De Lorenzo, F.; Iannellil, E.; Gitto, L.; Vaccaro, C. M.; Frontini, L.; Giannarelli, D.; Bryce, J.; Iacovino, M. L.; Piccirillo, M. C.; Jommi, C.; Efficace, F.; Riva, S.; Di Maio, M.; Gallo, C.; Perrone, F.
Assessment of innovativeness, and price and reimbursement negotiation of medicines: recommendations of an expert panel 1-gen-2024 Jommi, Claudio; Patarnello, Francesca; Bianchi, Cosetta; Buzzetti, Giuliano
The economic impact of 14 compassionate use programs for medicines in Italy, in the perspective of the National Health Service 1-gen-2024 Jommi, Claudio; Pantellini, Federico; Giuliani, Giovanni; Cavazza, Marianna
Early access programs for medicines: a reform proposal for the Italian National Health Service 1-gen-2024 Popoli, Patrizia; Giuliani, Giovanni; Cavaliere, Arturo; Jommi, Claudio
Cost of implementing CAR-T activity and managing CAR-T patients: an exploratory study 1-gen-2024 Cavallo, Maria Caterina; Cavazza, Marianna; Bonifazi, Francesca; Casadei, Beatrice; Cutini, Ilaria; Tonietti, Barbara; Saccardi, Riccardo; Zinzani, Pierluigi; Jommi, Claudio
From Indication-Based Pricing to Blended Approach: Evidence on the Price and Reimbursement Negotiation in Italy 1-gen-2024 Rossini, Elvio Emanuele; Galeone, Carlotta; Lucchetti, Chiara; Jommi, Claudio
Regional Formularies in Italy: current state and future perspectives 1-gen-2024 Bortolami, Alberto; Jommi, Claudio; Bresciani, Filippo; Piccoli, Luca; Sangiorgi, Elisa; Scroccaro, Giovanna
Content validity of the EQ-HWB and EQ-HWB-S in a sample of Italian patients, informal caregivers and members of the general public 1-gen-2024 Masutti, Sara; Falivena, Camilla; Purba, Fredrick Dermawan; Jommi, Claudio; Mukuria, Clara; Finch, Aureliano Paolo
Shortage of plasma-derived medicinal products: what is next? narrative literature review on its causes and counteracting policies in Italy 1-gen-2024 Bolcato, Matteo; Jommi, Claudio
Pharmaceutical pricing and managed entry agreements: An exploratory study on future perspectives in Europe 1-gen-2023 Jommi, Claudio; Bertolani, Arianna; Armeni, Patrizio; Costa, Francesco; Otto, Monica
Mostrati risultati da 1 a 20 di 204
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile